Shares of Sagility jumped 3.99% to ₹45.65 during Thursday’s trading session, driven by positive sentiment following a Jefferies report. The brokerage initiated a ‘Buy’ call on the stock with a target price of ₹52, indicating a potential upside of approximately 14%.
Jefferies highlighted Sagility’s robust positioning as a leading BPM firm focused on the US healthcare market, with expectations of double-digit revenue growth. The brokerage also projected a 40% CAGR in PAT and a 12% CAGR in revenue over FY25-27, supported by the normalization of D&A costs and deleveraging efforts.
As of 11:30 AM, the stock traded at a high of ₹46.09, with a volume of over 1.25 crore shares, reflecting strong investor interest.
Disclaimer: The above is for informational purposes only. Please consult a financial advisor before making any investment decisions.
